3D Medicines
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An integrated oncology company developing drugs paired with diagnostics for personalized cancer therapy.
OncologyImmunology
Technology Platform
An integrated 'Drug-Diagnostic-Data' platform for developing targeted immuno-oncology therapies paired with companion diagnostics.
Opportunities
Leveraging its integrated model to secure favorable reimbursement and hospital partnerships in China.
Risk Factors
Execution risk in managing two complex businesses and pricing pressure in both the oncology drug and diagnostic markets.
Competitive Landscape
Competes with large pharma in the crowded PD-1/PD-L1 market and with diagnostic giants like Burning Rock and Genetron.